Skip to main content

One-Dose MVA-BN Vaccine Moderately Effective Against Mpox

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 17, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Sept. 17, 2024 -- One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities, according to a study published online Sept. 11 in The BMJ.

Christine Navarro, M.D., from Public Health Ontario in Toronto, and colleagues estimated the real-world effectiveness of the MVA-BN vaccine against mpox infection in an emulation of a target trial involving 9,803 men with a history of being tested for syphilis and a laboratory-confirmed bacterial sexually transmitted infection in the previous year or who filled a prescription for HIV pre-exposure prophylaxis in the previous year. Those who had been vaccinated 15 days previously were matched with unvaccinated men in a 1:1 ratio on each day between June 12 and Oct. 27, 2022. A total of 3,204 men who received the vaccine were matched with 3,204 unvaccinated controls.

The researchers identified 71 mpox infections, with 0.09 and 0.20 per 1,000 person-days in the vaccinated and unvaccinated groups, respectively, during the study period of 153 days. For one dose of MVA-BN, the estimated vaccine effectiveness against mpox infection was 58 percent.

"Our findings strengthen the evidence that MVA-BN is effective at preventing mpox infection and should be made available and accessible to communities at risk," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

CDC Provides Update on Measles Outbreak in the United States

TUESDAY, April 29, 2025 -- Eight hundred cases of measles were reported in the United States as of April 17, 2025, representing the second highest annual case count in 25 years...

Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility

MONDAY, April 7, 2025 -- Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.